Opioid-free analgesia with esketamine-dexmedetomidine versus opioid-based analgesia after gynaecological laparoscopic surgery: a double-blind, randomized, controlled trial.

Ann MedSep 16, 2026 (epub)

Ying Ren, Yu-Ting Li, Qiao-Li Yin et al.

✦ AI-curated · Sources linked

In 30 seconds

This double-blind, randomized controlled trial evaluated opioid-free analgesia using esketamine and dexmedetomidine versus sufentanil in 134 adult patients post-gynaecological laparoscopic surgery. The opioid-free approach demonstrated non-inferior pain control (AUC 175 vs 169) and significantly improved quality of recovery (QoR-15 score 116 vs 108), suggesting it as a viable alternative to opioid-based analgesia.

Key findings

  • Pain control was non-inferior in the opioid-free group with AUC 175 vs 169.
  • The mean QoR-15 score was significantly higher in the opioid-free group at 116 vs 108.
  • The opioid-free group showed better physical comfort and emotional state scores.
  • No serious adverse events occurred in either group.

Why it matters

The findings suggest that opioid-free analgesia can effectively manage postoperative pain while enhancing recovery quality, addressing concerns related to opioid side effects. This approach may improve patient outcomes in surgical settings.

Source

Published in Ann Med. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Anesthesiology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.